TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 OVERVIEW OF THE NORTH AMERICA LAB AUTOMATION MARKET 15
1.4 LIMITATIONS 17
1.5 MARKETS COVERED 17
2 MARKET SEGMENTATION 19
2.1 MARKETS COVERED 19
2.2 GEOGRAPHICAL SCOPE 20
2.3 YEARS CONSIDERED FOR THE STUDY 21
2.4 CURRENCY AND PRICING 21
2.5 DBMR TRIPOD DATA VALIDATION MODEL 22
2.6 MULTIVARIATE MODELLING 25
2.7 PRODUCT TYPE LIFELINE CURVE 25
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
2.9 DBMR MARKET POSITION GRID 27
2.10 MARKET END USER COVERAGE GRID 28
2.11 VENDOR SHARE ANALYSIS 29
2.12 SECONDARY SOURCES 30
2.13 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 33
4.1 PESTEL ANALYSIS 34
4.2 PORTERS FIVE FORCES 35
5 REGULATION 36
6 MARKET OVERVIEW 38
6.1 DRIVERS 40
6.1.1 INCREASING INVESTMENT & STRATEGIC INITIATIVES BY MARKET PLAYERS 40
6.1.2 GOVERNMENT INITIATIVES TO STRENGTHEN LABORATORY INFRASTRUCTURES 40
6.1.3 GROWING EXPENDITURE ON LAB AUTOMATION TOOLS AND EQUIPMENT 40
6.1.4 REDUCING HUMAN EFFORTS AND ELIMINATING HUMAN ERROR 41
6.2 RESTRAINTS 41
6.2.1 LIMITATION ANALYZING NOVEL COMPLEX PRODUCT 41
6.2.2 HIGH COST FOR INSTALLATION AND SETUP 41
6.2.3 UPGRADATION, MAINTENANCE, AND PERIODICAL CHECKUPS 42
6.3 OPPORTUNITIES 42
6.3.1 RISING HEALTHCARE EXPENDITURE 42
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 43
6.3.3 RISE IN THE NUMBER OF PHARMA COMPANIES 43
6.4 CHALLENGES 44
6.4.1 SLOW ADOPTION OF AUTOMATION AMONG SMALL AND MEDIUM SIZED LABORATORIES 44
6.4.2 LIMITED FEASIBILITY WITH TECHNOLOGY INTEGRATION IN ANALYTICAL LABS 44
7 NORTH AMERICA LAB AUTOMATION MARKET, BY PRODUCT TYPE 45
7.1 OVERVIEW 46
7.2 EQUIPMENT 49
7.2.1 AUTOMATED WORKSTATIONS 49
7.2.1.1 AUTOMATED LIQUID HANDLING SYSTEMS 49
7.2.1.2 AUTOMATED INTEGRATED WORKSTATIONS 49
7.2.1.3 PIPETTING SYSTEMS 50
7.2.1.4 MICROPLATE WASHERS 50
7.2.1.5 REAGENT DISPENSERS 50
7.2.2 MICROPLATE READERS 50
7.2.2.1 MULTI-MODE MICROPLATE READERS 50
7.2.2.2 SINGLE-MODE MICROPLATE READERS 50
7.2.2.3 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS 50
7.2.2.4 AUTOMATED ELISA SYSTEMS 51
7.2.3 OFF-THE-SHELF AUTOMATED WORKCELLS 51
7.2.4 ROBOTIC SYSTEMS 51
7.2.4.1 ROBOTIC ARMS 51
7.2.4.2 TRACK ROBOTS 51
7.2.5 AUTOMATE STORAGE & RETRIEVALS (ASRS) 51
7.2.6 OTHERS 51
7.3 ANALYZER 51
7.3.1 BIO CHEMISTRY ANALYZERS 52
7.3.2 HAEMATOLOGY ANALYZERS 52
7.3.3 IMMUNO-BASED ANALYZERS 52
7.4 SOFTWARE & INFORMATICS 52
7.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEM (LIMS) 53
7.4.2 ELECTRONIC LABORATORY NOTEBOOK (ELN) 53
7.4.3 LABORATORY EXECUTION SYSTEMS (LES) 53
7.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS (SDMS) 54
8 NORTH AMERICA LAB AUTOMATION MARKET, BY AUTOMATION TYPE 55
8.1 OVERVIEW 56
8.2 TOTAL LAB AUTOMATION 59
8.3 MODULAR AUTOMATION 59
9 NORTH AMERICA LAB AUTOMATION MARKET, BY APPLICATION 60
9.1 OVERVIEW 61
9.2 CLINICAL DIAGNOSTICS 64
9.3 DRUG DISCOVERY 64
9.4 GENOMICS SOLUTIONS 64
9.5 PROTEOMIC SOLUTIONS 65
9.6 ANALYTICAL CHEMISTRY 65
9.7 PROTEIN ENGINEERING 66
9.8 BIO ANALYSIS 66
9.9 SYSTEM BIOLOGY 67
9.10 OTHERS 67
10 NORTH AMERICA LAB AUTOMATION MARKET, BY END USER 69
10.1 OVERVIEW 70
10.2 BIOTECHNOLOGY & PHARMACEUTICALS 73
10.3 HOSPITALS & LABORATORIES 73
10.4 RESEARCH & ACADEMIC INSTITUTES 73
10.5 OTHERS 74
11 NORTH AMERICA LAB AUTOMATION MARKET, BY REGION 75
11.1 NORTH AMERICA 76
11.1.1 U.S. 84
11.1.2 CANADA 87
11.1.3 MEXICO 91
12 NORTH AMERICA LAB AUTOMATION MARKET: COMPANY LANDSCAPE 95
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 95
13 SWOT ANALYSIS 96
14 COMPANY PROFILE 97
14.1 THERMO FISHER SCIENTIFIC INC. 97
14.1.1 COMPANY SNAPSHOT 97
14.1.2 REVENUE ANALYSIS 98
14.1.3 COMPANY SHARE ANALYSIS 98
14.1.4 PRODUCT PORTFOLIO 98
14.1.5 RECENT DEVELOPMENTS 99
14.2 DANAHER 100
14.2.1 COMPANY SNAPSHOT 100
14.2.2 REVENUE ANALYSIS 100
14.2.3 COMPANY SHARE ANALYSIS 101
14.2.4 PRODUCT PORTFOLIO 101
14.2.5 RECENT DEVELOPMENTS 101
14.3 F. HOFFMANN- LA ROCHE LTD 102
14.3.1 COMPANY SNAPSHOT 102
14.3.2 REVENUE ANALYSIS 102
14.3.3 COMPANY SHARE ANALYSIS 103
14.3.4 PRODUCT PORTFOLIO 103
14.3.5 RECENT DEVELOPMENTS 103
14.4 PERKINELMER INC 105
14.4.1 COMPANY SNAPSHOT 105
14.4.2 REVENUE ANALYSIS 106
14.4.3 COMPANY SHARE ANALYSIS 106
14.4.4 PRODUCT PORTFOLIO 107
14.4.5 RECENT DEVELOPMENTS 107
14.5 BD 108
14.5.1 COMPANY SNAPSHOT 108
14.5.2 REVENUE ANALYSIS 108
14.5.3 COMPANY SHARE ANALYSIS 109
14.5.4 PRODUCT PORTFOLIO 109
14.5.5 RECENT DEVELOPMENTS 109
14.6 ABBOTT 110
14.6.1 COMPANY SNAPSHOT 110
14.6.2 REVENUE ANALYSIS 110
14.6.3 PRODUCT PORTFOLIO 111
14.6.3 RECENT DEVELOPMENTS 111
14.7 AGILENT TECHNOLOGIES 112
14.7.1 COMPANY SNAPSHOT 112
14.7.2 REVENUE ANALYSIS 112
14.7.3 PRODUCT PORTFOLIO 113
14.7.4 RECENT DEVELOPMENTS 113
14.8 AURORA BIOMED INC. 114
14.8.1 COMPANY SNAPSHOT 114
14.8.2 PRODUCT PORTFOLIO 114
14.8.3 RECENT DEVELOPMENTS 114
14.9 AZENTA US INC 115
14.9.1 COMPANY SNAPSHOT 115
14.9.2 REVENUE ANALYSIS 115
14.9.3 PRODUCT PORTFOLIO 116
14.9.4 RECENT DEVELOPMENTS 116
14.10 BIOMERIEUX 117
14.10.1 COMPANY SNAPSHOT 117
14.10.2 REVENUE ANALYSIS 117
14.10.3 PRODUCT PORTFOLIO 118
14.10.4 RECENT DEVELOPMENTS 118
14.11 EPPENDORF SE 119
14.11.1 COMPANY SNAPSHOT 119
14.11.2 PRODUCT PORTFOLIO 119
14.11.3 RECENT DEVELOPMENTS 119
14.12 HAMILTON COMPANY 120
14.12.1 COMPANY SNAPSHOT 120
14.12.2 PRODUCT PORTFOLIO 120
14.12.3 RECENT DEVELOPMENTS 120
14.13 HUDSON ROBOTICS 121
14.13.1 COMPANY SNAPSHOT 121
14.13.2 PRODUCT PORTFOLIO 121
14.13.3 RECENT DEVELOPMENTS 121
14.14 LABLYNX LIMS 122
14.14.1 COMPANY SNAPSHOT 122
14.14.2 PRODUCT PORTFOLIO 122
14.14.3 RECENT DEVELOPMENTS 122
14.15 LABVANTAGE SOLUTIONS INC. 123
14.15.1 COMPANY SNAPSHOT 123
14.15.2 PRODUCT PORTFOLIO 123
14.15.3 RECENT DEVELOPMENTS 123
14.16 LABWARE 124
14.16.1 COMPANY SNAPSHOT 124
14.16.2 PRODUCT PORTFOLIO 124
14.16.3 RECENT DEVELOPMENTS 124
14.17 QIAGEN 125
14.17.1 COMPANY SNAPSHOT 125
14.17.2 REVENUE ANALYSIS 125
14.17.3 PRODUCT PORTFOLIO 126
14.17.4 RECENT DEVELOPMENTS 126
14.18 SIEMENS HEALTHCARE GMBH 128
14.18.1 COMPANY SNAPSHOT 128
14.18.2 REVENUE ANALYSIS 128
14.18.3 PRODUCT PORTFOLIO 129
14.18.4 RECENT DEVELOPMENTS 129
14.19 TECAN TRADING AG 130
14.19.1 COMPANY SNAPSHOT 130
14.19.2 REVENUE ANALYSIS 130
14.19.3 PRODUCT PORTFOLIO 131
14.19.4 RECENT DEVELOPMENTS 131
15 QUESTIONNAIRE 132
16 RELATED REPORTS 135

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.